1Toby M. Maher, Athol U. Wells Lost in translation; from animal models of pulmonary fibrosis to human disease [ J ]. Respimlogy, 2009,14 : 915 - 916.
2Waseda Y, Yasui. M, Nishizawa Y, et al. Type 2 receptor antagonist reduces bleomycin- induced pulmonary fibrosis in mice[ J]. Respir Res ,2008,9 - 43.
3Sriram N, Kalayarasan S, Sudhandiran G. Enhancement of antioxidant defense system by epigallocateehin-3-gallate during bleomyein induced experimental pulmonary fibrosis [ J ]. Biol Pharm Bull, 2008,31 (7) :1306 - 1311.
8Barbarin V, Nihoul A, Misson P, et al. The role of pro- and antiinflammatory responses in silica induced lung fibrosis [ J ]. Respir Res,2005,6 : 112.
9Lakatos HF, Burgess HA, Thatcher TH,et al. Oropharyngeal aspiration of a silica suspension produces a superior model of silicosis in the mouse when compared to intratracheal instillation[ J]. Exp Lung Res.2006. 32 : 181 - 199.
10Bonniaud P, Margetts PJ, Ask K, et al. TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis [ J ]. J Immunol, 2005.175 : 5390 -5395.
8Antoniou K M, Alexandrakis M G. Cytokine network in pathogenesis of idiopathic pulmonary fibrosis[J]. Sarcoidosis Vasc Diffuse Lung Dis, 2005; 22(2) :91-95.
9Wang Q J, Wang Y J, Dallas Met ol. Effect of antibody againstinte grin onBleomycin induced pulmonary fibrosis in mice[J]. Biochem Pharmae, 2000;60(12) : 1949-1958.
10Clark J G, Kostal K M, Marino B A. Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine mono-phosphate and suppresses fibroblast proliferation and collagen production [ J ]. J Clin Invest, 1983 ; 72 (6) : 2082-2091.
